Clinical Trial Update: Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing potential interactions between cocaine and GBR-12909 (vanoxerine). Sponsored by the National Institute on Drug Abuse (NIDA) in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• Vanoxerine (GBR 12909) (vanoxerine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: UNKNOWN